Liraglutide preserves renal function in overweight diabetic patients with stage 3 chronic kidney disease

被引：8

作者：

Garcia de Lucas, Maria Dolores ^{[1
]}

Aviles Bueno, Beatriz ^{[2
]}

Olalla Sierra, Julian ^{[1
]}

机构：

[1] Hosp Costa Sol, Dept Internal Med, Marbella, Spain

[2] Hosp Costa Sol, Dept Nephrol, Marbella, Spain

来源：

EUROPEAN JOURNAL OF INTERNAL MEDICINE | 2017年 / 44卷

关键词：

Liraglutide; HbA(1c); Chronic kidney disease; Albuminuria; Weight; Hypoglycaemia; CARDIOVASCULAR OUTCOMES; TYPE-2; WEIGHT;

D O I：

10.1016/j.ejim.2017.07.020

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：E28 / E29

页数：2

共 8 条

[1]

Amer Diabet Assoc, 2018, DIABETES CARE, V41, pS13, DOI [10.2337/dc19-S002, 10.2337/dc18-S002, 10.2337/dc09-S062, 10.2337/dc12-S064]

[2] Achieving glycemic control in patients with type 2 diabetes and renal impairment [J].

Avogaro, Angelo ;

Schernthaner, Guntram .

ACTA DIABETOLOGICA, 2013, 50 (03) :283-291

[3] Efficacy of Liraglutide for Weight Loss Among Patients With Type 2 Diabetes The SCALE Diabetes Randomized Clinical Trial [J].

Davies, Melanie J. ;

Bergenstal, Richard ;

Bode, Bruce ;

Kushner, Robert F. ;

Lewin, Andrew ;

Skjoth, Trine Vang ;

Andreasen, Arne Haahr ;

Jensen, Christine Bjorn ;

DeFronzo, Ralph A. .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2015, 314 (07) :687-699

[4] Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes [J].

Marso, Steven P. ;

Daniels, Gilbert H. ;

Brown-Frandsen, Kirstine ;

Kristensen, Peter ;

Mann, Johannes F. E. ;

Nauck, Michael A. ;

Nissen, Steven E. ;

Pocock, Stuart ;

Poulter, Neil R. ;

Ravn, Lasse S. ;

Steinberg, William M. ;

Stockner, Mette ;

Zinman, Bernard ;

Bergenstal, Richard M. ;

Buse, John B. .

NEW ENGLAND JOURNAL OF MEDICINE, 2016, 375 (04) :311-322

[5] Use of Liraglutide in the Real World and Impact at 36 Months on Metabolic Control, Weight, Lipid Profile, Blood Pressure, Heart Rate, and Renal Function [J].

Rondinelli, Maurizio ;

Rossi, Antonio ;

Gandolfi, Alessandra ;

Saponaro, Fabio ;

Bucciarelli, Loredana ;

Adda, Guido ;

Molinari, Chiara ;

Montefusco, Laura ;

Specchia, Claudia ;

Rossi, Maria Chiara ;

Scardapane, Marco ;

Arosio, Maura ;

Genovese, Stefano .

CLINICAL THERAPEUTICS, 2017, 39 (01) :159-169

[6] Short-term effects of liraglutide on kidney function and vasoactive hormones in type 2 diabetes: a randomized clinical trial [J].

Skov, J. ;

Pedersen, M. ;

Holst, J. J. ;

Madsen, B. ;

Goetze, J. P. ;

Rittig, S. ;

Jonassen, T. ;

Frokiaer, J. ;

Dejgaard, A. ;

Christiansen, J. S. .

DIABETES OBESITY & METABOLISM, 2016, 18 (06) :581-589

[7] The effect of liraglutide on renal function: A randomized clinical trial [J].

von Scholten, Bernt J. ;

Persson, Frederik ;

Rosenlund, Signe ;

Hovind, Peter ;

Faber, Jens ;

Hansen, Tine W. ;

Rossing, Peter .

DIABETES OBESITY & METABOLISM, 2017, 19 (02) :239-247

[8] Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes [J].

Zinman, Bernard ;

Wanner, Christoph ;

Lachin, John M. ;

Fitchett, David ;

Bluhmki, Erich ;

Hantel, Stefan ;

Mattheus, Michaela ;

Devins, Theresa ;

Johansen, Odd Erik ;

Woerle, Hans J. ;

Broedl, Uli C. ;

Inzucchi, Silvio E. ;

Aizenberg, D. ;

Ulla, M. ;

Waitman, J. ;

De Loredo, L. ;

Farias, J. ;

Fideleff, H. ;

Lagrutta, M. ;

Maldonado, N. ;

Colombo, H. ;

Ferre Pacora, F. ;

Wasserman, A. ;

Maffei, L. ;

Lehman, R. ;

Selvanayagam, J. ;

d'Emden, M. ;

Fasching, P. ;

Paulweber, B. ;

Toplak, H. ;

Luger, A. ;

Drexel, H. ;

Prager, R. ;

Schnack, C. ;

Schernthaner, G. ;

Fliesser-Goerzer, E. ;

Kaser, S. ;

Scheen, A. ;

Van Gaal, L. ;

Hollanders, G. ;

Kockaerts, Y. ;

Capiau, L. ;

Chachati, A. ;

Persu, A. ;

Hermans, M. ;

Vantroyen, D. ;

Vercammen, C. ;

Van de Borne, P. ;

Mathieu, C. ;

Benhalima, K. .

NEW ENGLAND JOURNAL OF MEDICINE, 2015, 373 (22) :2117-2128

← 1 →